Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging therapeutic strategies in muscular dystrophy: an updated review on pathogenesis and treatment advances. | Mol Biol Rep | 2026 | 41524923 | PubTator, text mining | PubMed |
| Pathological mechanism in Fuchs endothelial corneal dystrophy and myotonic dystrophy type 1: more than meets the eye. | Prog Retin Eye Res | 2026 | 41285302 | PubTator, text mining | PubMed |
| Genetic analysis in fetuses with isolated clubfoot: diagnostic insights and added value. | Eur J Hum Genet | 2026 | 41272104 | PubTator, text mining | PubMed |
| Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing. | Prenat Diagn | 2026 | 41260620 | PubTator, text mining | PubMed |
| Analysis of muscle and blood RNA samples from patients with myotonic dystrophy type 1 reveals the presence of new mis-splicing biomarkers of disease severity. | J Med Genet | 2026 | 41161721 | PubTator, text mining | PubMed |
| Association of Non-Coding Repeat Expansions with Parkinson's Disease Risk: Evidence from a UK Biobank-Based Whole-Genome Sequencing Study. | Mov Disord | 2026 | 41074692 | PubTator, text mining | PubMed |
| Co-Opting MBNL-Dependent Alternative Splicing Cassette Exons to Control Gene Therapy in Myotonic Dystrophy. | Ann Neurol | 2026 | 40879030 | PubTator, text mining | PubMed |
| Changes in RNA splicing as a surrogate endpoint for myotonic dystrophy Type 1 (DM1) clinical trials. | J Neuromuscul Dis | 2026 | 40808372 | PubTator, text mining | PubMed |
| Neonatal congenital myotonic dystrophy with DMPK gene expansion: clinical features and short-term outcomes. | Front Pediatr | 2025 | 41585019 | PubTator, text mining | PubMed |
| Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. | Genes (Basel) | 2025 | 41465188 | PubTator, text mining | PubMed |
| Estimating weaning duration from incremental dentine δ15N and δ13C using a sequence-based LSTM neural network: A deep learning framework for bioarchaeological applications. | PLoS One | 2025 | 41406149 | PubTator, text mining | PubMed |
| Technical guidelines for non-clinical pharmacological research of traditional Chinese medicine (TCM) formulae. | Chin Med | 2025 | 41331836 | PubTator, text mining | PubMed |
| Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies. | Int J Mol Sci | 2025 | 41303475 | PubTator, text mining | PubMed |
| Multi-ancestry Transcriptome-Wide Association Study Reveals Shared and Population-Specific Genetic Effects in Alzheimer's Disease. | bioRxiv | 2025 | 41279621 | PubTator, text mining | PubMed |
| Investigation on LASSBio-1971 and LASSBio-1974 Cellular Cytotoxic Mechanism and Their Comparative DMPK Profile. | Arch Pharm (Weinheim) | 2025 | 41269051 | PubTator, text mining | PubMed |
| From molecular convergence to clinical divergence: Comparative pathogenic mechanisms and therapeutic trajectories in C9orf72-ALS/FTD and myotonic dystrophy. | Neurobiol Dis | 2025 | 41260310 | PubTator, text mining | PubMed |
| Characterization of DMPK and MBNL1 expression in cell models of myotonic dystrophy: a platform for drug screening. | NAR Mol Med | 2025 | 41256290 | PubTator, text mining | PubMed |
| Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1. | J Cachexia Sarcopenia Muscle | 2025 | 41250834 | PubTator, text mining | PubMed |
| A 12-Week Strength Training Improves Mitochondrial Respiration, H2O2 Emission and Skeletal Muscle Integrity in Women With Myotonic Dystrophy Type 1. | Acta Physiol (Oxf) | 2025 | 41241935 | PubTator, text mining | PubMed |
| AAV-mediated DMPK silencing: A defining moment in myotonic dystrophy type 1 therapeutics. | Mol Ther | 2025 | 41240904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=4